![]() Genelux Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform. | ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. | ![]() Alchemab Therapeutics Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies. | |
Founding Date | Founding Date 2001 | Founding Date 2016 | Founding Date 2019 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Thousand Oaks, US HQ | Locations HQ | Locations London, GB HQ Babraham, GB |
Employees | Employees 157% increase | Employees 615% increase | Employees 512% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 65m (almost 8 years ago) | Latest funding round $ 71.8m (about 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 90.8m | Total funding raised $ 71.8m |
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View company
Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.
View company